Metabolomics Market Growth, Size, Share, Trends, and Forecast 2032

According to the report published by Zion Market Research, the global Metabolomics Market size was valued at USD 2,753.10 Million in 2023 and is predicted to reach USD 8,605.50 Million by the end of 2032. The market is expected to grow with a CAGR of 13.50% during the forecast period. The report analyzes the global Metabolomics Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Metabolomics Market industry.

Request Free Sample

Global Metabolomics Market: Overview

The metabolites exist in an organism, cell, or tissue; the study related to it is referred as metabolomics. In order to understand the complete set of metabolites in a given biological system processes such as quantification, profiling, interpretation, and identification are involved. This latest field of science is gaining much popularity as it provides the complete outlook of the organelles, cells, tissues, organs, and whole organisms’ phenotype when compared to the protein profile, RNA, or DNA.

Global Metabolomics Market: Segmentation

The metabolomics market is globally segmented into product and service, application, and indication.

On the basis of product and service, the global market is segregated into metabolomic instruments and metabolomic bioinformatics tools and services. Further, the metabolomic instruments segment is sub-segmented into separation techniques and detection techniques. The metabolomic bioinformatics tools segment is sub-segmented into bioinformatics services and bioinformatics tools & database.

Based on the application, the market is categorized into drug discovery/drug assessment, toxicology testing, functional genomics, biomarker discovery, nutrigenomics, personalized medicine, and others.

Depending on the indication, the market is divided into cardiovascular disorders, inborn errors of metabolism, cancer, neurological disorders, and others.

Request Free Sample

Global Metabolomics Market: Growth Factors

The key driver that is contributing to the metabolomics market is the high investments that are made by government bodies and private players in the development and the research of the efficient metabolomics. The factors that support the global market are the untapped potential of the emerging economies and the continuous technological advancements that are made in this field. The position of metabolomics has become very crucial in the field of medicine owing to the fact that they provide deep understanding of how the diseases function. They also provide protein profiling.

Metabolomics Market : Report Scope

Global Metabolomics Market: Regional Analysis

Geographically, the metabolomics market is diversified into North America, Latin America, Europe, Asia-Pacific, and Rest of the World. The region that dominates the metabolomics market is the North America. The key factors that attribute to this growth are the strong research infrastructure and the increasing demand for the medicines that are personalized. The wide acceptance of the technologically advanced products among the consumers anticipates increasing the regional market growth in the coming years. Asia Pacific region also shows progress in the metabolomics market.

The factors that attribute to this market growth are the increasing aging population and the increasing cases of a wide range of illness have opened up opportunities for the pharmaceutical companies in the region, thus driving the metabolomics market in the Asia Pacific region. The other factors that contribute to the market growth in the Asia-Pacific region are increased demand for access to healthcare facilities, improved healthcare, and pharmaceutical products, and investments in life sciences have opened new avenues to the growth of the market.

Global Metabolomics Market: Competitive Players

Some of the major companies in the metabolomics market include:

• Shimadzu Corporation
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Danaher Corporation
• Human Metabolome Technologies Inc.
• LECO Corporation
• Agilent Technologies, Inc.
• Biocrates Life Sciences AG
• Thermo Fisher Scientific, Inc.
• Waters Corporation,
• Metabolon Inc.

The Global Metabolomics Market is segmented as follows:

By Product and service 

• metabolomic instruments 
• metabolomic bioinformatics tools and services 

By Application 

• drug discovery/drug assessment 
• toxicology testing 
• functional genomics
• biomarker discovery 
• nutrigenomics 
• personalized medicine 
• and others

By Indication 

• cardiovascular disorders 
• inborn errors of metabolism 
• cancer 
• neurological disorders
• and others

Global Metabolomics Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.